These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 3432453)

  • 1. Diminished prolactin responses to repeated fenfluramine challenge in man.
    Coccaro EF; Siever LJ; Klar H; Rubenstein K; Benjamin E; Davis KL
    Psychiatry Res; 1987 Nov; 22(3):257-9. PubMed ID: 3432453
    [No Abstract]   [Full Text] [Related]  

  • 2. Central serotonin activity and aggression: inverse relationship with prolactin response to d-fenfluramine, but not CSF 5-HIAA concentration, in human subjects.
    Coccaro EF; Kavoussi RJ; Cooper TB; Hauger RL
    Am J Psychiatry; 1997 Oct; 154(10):1430-5. PubMed ID: 9326827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced prolactin and cortisol responses to d-fenfluramine in depressed compared to healthy matched control subjects.
    Cleare AJ; Murray RM; O'Keane V
    Neuropsychopharmacology; 1996 May; 14(5):349-54. PubMed ID: 8703303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated cortisol concentrations and the diminished prolactin response to fenfluramine.
    Mitchell PB; Smythe GA
    Am J Psychiatry; 1992 Jun; 149(6):851-2. PubMed ID: 1590517
    [No Abstract]   [Full Text] [Related]  

  • 5. The neuroendocrine response to fenfluramine in depressives and normal controls.
    Asnis GM; Eisenberg J; van Praag HM; Lemus CZ; Friedman JM; Miller AH
    Biol Psychiatry; 1988 May; 24(1):117-20. PubMed ID: 3370273
    [No Abstract]   [Full Text] [Related]  

  • 6. Prolactin and cortisol responses to d-fenfluramine in major depression: evidence for diminished responsivity of central serotonergic function.
    O'Keane V; Dinan TG
    Am J Psychiatry; 1991 Aug; 148(8):1009-15. PubMed ID: 1853948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced serotonergic responsivity following electroconvulsive therapy in patients with major depression.
    Shapira B; Lerer B; Kindler S; Lichtenberg P; Gropp C; Cooper T; Calev A
    Br J Psychiatry; 1992 Feb; 160():223-9. PubMed ID: 1540763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal behavioral responses to fenfluramine in patients with affective and personality disorders. Correlation with increased serotonergic responsivity.
    Myers JE; Mieczkowski T; Perel J; Abbondanza D; Cooper TB; Mann JJ
    Biol Psychiatry; 1994 Jan; 35(2):112-20. PubMed ID: 8167207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behavior.
    Coccaro EF; Siever LJ; Klar HM; Maurer G; Cochrane K; Cooper TB; Mohs RC; Davis KL
    Arch Gen Psychiatry; 1989 Jul; 46(7):587-99. PubMed ID: 2735812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormonal responses to fenfluramine in depressive subtypes.
    Mitchell P; Smythe G; Parker G; Wilhelm K; Hickie I; Brodaty H; Boyce P
    Br J Psychiatry; 1990 Oct; 157():551-7. PubMed ID: 2131137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of imipramine treatment on the prolactin response to fenfluramine and placebo challenge in depressed patients.
    Shapira B; Reiss A; Kaiser N; Kindler S; Lerer B
    J Affect Disord; 1989; 16(1):1-4. PubMed ID: 2521644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortisol and prolactin responses to d-fenfluramine in non-depressed patients with obsessive-compulsive disorder: a comparison with depressed and healthy controls.
    Lucey JV; O'Keane V; Butcher G; Clare AW; Dinan TG
    Br J Psychiatry; 1992 Oct; 161():517-21. PubMed ID: 1393339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced prolactin response to fenfluramine challenge in personality disorder patients is not due to deficiency of pituitary lactotrophs.
    Coccaro EF; Klar H; Siever LJ
    Biol Psychiatry; 1994 Sep; 36(5):344-6. PubMed ID: 7993962
    [No Abstract]   [Full Text] [Related]  

  • 14. Hormone responses to fenfluramine and placebo challenge in endogenous depression.
    Lichtenberg P; Shapira B; Gillon D; Kindler S; Cooper TB; Newman ME; Lerer B
    Psychiatry Res; 1992 Aug; 43(2):137-46. PubMed ID: 1410069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma prolactin changes following fenfluramine in depressed patients compared to controls: an evaluation of central serotonergic responsivity in depression.
    Siever LJ; Murphy DL; Slater S; de la Vega E; Lipper S
    Life Sci; 1984 Mar; 34(11):1029-39. PubMed ID: 6700367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroendocrine challenges in the diagnosis of depressive disorders.
    López-Ibor JJ; Saiz-Ruiz J; Moral Iglesias L
    Br J Psychiatry Suppl; 1989 May; (4):73-6. PubMed ID: 2605013
    [No Abstract]   [Full Text] [Related]  

  • 17. Re: Endocrine responses to fenfluramine challenge in chronic fatigue syndrome.
    Cleare AJ; O'Keane V
    Can J Psychiatry; 1996 Mar; 41(2):129-31. PubMed ID: 8705960
    [No Abstract]   [Full Text] [Related]  

  • 18. Prolactin response to fenfluramine and suicide attempt lethality in major depression.
    Malone KM; Corbitt EM; Li S; Mann JJ
    Br J Psychiatry; 1996 Mar; 168(3):324-9. PubMed ID: 8833686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortisol synthesis inhibition: a new treatment strategy for the clinical and endocrine manifestations of depression.
    Thakore JH; Dinan TG
    Biol Psychiatry; 1995 Mar; 37(6):364-8. PubMed ID: 7772644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cortisol, ACTH, prolactin and beta-endorphin responses to fenfluramine administration in major-depressed patients.
    Maes M; Jacobs MP; Suy E; Minner B; Raus J
    Neuropsychobiology; 1989; 21(4):192-6. PubMed ID: 2561010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.